NEW YORK, Nov. 14, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Vascular Solutions, Inc. ("Vascular" or the "Company") (NASDAQ: VASC). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 237.
The investigation concerns whether Vascular and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On November 13, 2014, the U.S. Department of Justice filed a criminal indictment in the United States District Court for the Western District of Texas related to the Vari-Lase Short Kit investigation. The indictment alleges that Vascular Solutions and its Chief Executive Officer introduced adulterated and misbranded medical devices into interstate commerce, and conspired to introduce such adulterated and misbranded products to the market.
On this news, shares of Vascular fell $3.35 per share, or more than 10.98%, to close at $27.15 per share on October 29, 2014.
The Pomerantz Firm, with offices in New York, Chicago, San Diego and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
Robert S. Willoughby
SOURCE Pomerantz LLP